Patent Grant
11359044
The disclosure herein relates to preparation and application of a novel multifunctional nanocomposite material with new photosensitizer, specifically relates to cercosporin which is further coated into an acid-sensitive copolymer with liver tumor cell targeting ability and traceability to prepare the novel photosensitizer multifunctional nanocomposite material, and a preparation method and application thereof, belonging to the technical field of photodynamic therapy and the field of biomedicine.
Photodynamic therapy is a non-invasive new technology for treatment of tumor diseases. By incubating a photosensitizer and combining with specific light irradiation, singlet oxygen with high oxidizability can be produced, thereby achieving the purpose of killing tumor tissues and cells. After years of development, photodynamic therapy has become more and more widely used, and its mechanism of action has become increasingly clear. Photodynamic therapy for treatment of malignant tumors requires three elements: photosensitizer, light irradiation with specific wavelength and oxygen. The treatment strategy is as follows: a low-toxic photosensitizer enters the body; then light is applied to a tumor area to excite the photosensitizer; the photosensitizer in an excited triplet state after photoactivation transfers the excited state energy to the oxygen in the surrounding tumor tissues and cells to produce singlet oxygen with high oxidizability, thereby oxidatively damaging liposomes, proteins and other subcellular organelles, and further causing tumor cell apoptosis and necrosis. Therefore, the performance of the photosensitizer to produce singlet oxygen is critical to the effect of photodynamic therapy. However, the photosensitizer commonly used has poor water-solubility and does not have tumor targeting ability, which severely restricts its clinical application. Therefore, many scientific studies have enhanced the water solubility and targeting ability of various photosensitizers by means of chemical modification or nano-delivery systems to meet the application of the photodynamic therapy technology in the field of biomedicine.
After decades of development, the types and performance of photosensitizers have been fully developed, and the photosensitizers have developed to the third generation: the first and second generation photosensitizers are mainly classified into porphyrin derivatives, meso-aryl-substituted porphins, phthalocyanines, chlorophyll a degradation product derivatives and hematoporphyrin monomethyl ether; the third-generation photosensitizers mainly refer to functionalized derivatives of the second-generation photosensitizers, including amino acid-coupled photosensitizers, polymer-coupled photosensitizers, protein or sugar-coupled photosensitizers, and other photosensitizers with molecular recognition function. The development of each generation of photosensitizers is accompanied by improvements in its phototherapy performance, particularly in terms of hydrophilicity and targeting ability. At present, in medical application of photodynamic therapy, the comparatively mature photosensitizers include porphyrins, porphins and phthalocyanines. In addition, a novel photosensitive material, cercosporin, is a perylenequinonoid-based photosensitive compound isolated from the genus Cercospora, and has high singlet oxygen quantum yield (0.81). However, similar to other photosensitizers, cercosporin has poor water-solubility and lacks targeting ability, its photodynamic therapy function has not yet been developed, and currently, there is no report on its use as a photosensitizer in photodynamic therapy.
Polymer micelles are a kind of nano-delivery systems, and amphiphilic macromolecules with good biocompatibility can self-assemble into micelles in water. The hydrophobic photosensitizer can be constructed into a photosensitizer-loaded micelle in the form of drug-loading or performing hydrophilic modification to meet the requirements of photodynamic therapy. In addition, due to special growth properties of tumor tissues or cells, multiple targeting receptors can be overexpressed on the surface of cell membranes; while some functional targeting molecules, such as antibodies, peptides, carbohydrates, etc., can specifically recognize these receptors, and thus can be modified on the surface of the polymer micelles, so the polymer micelles can be ingested by tumor cells in a large amount through receptor-mediated recognition, thereby achieving targeted delivery of the photosensitizer for photodynamic therapy, and reducing the toxicity of photodynamic therapy to normal cells.
In order to solve the shortcomings of low water solubility and lack of targeting ability of photosensitizers in photodynamic therapy and develop the potential of cercosporin in photodynamic therapy, the present disclosure applies cercosporin to multifunctional nanocomposite materials for the first time, thereby reducing its toxic and side effects and developing its potential in photodynamic therapy.
The novel multifunctional nanocomposite material with new photosensitizer provided by the present disclosure is prepared by self-assembly of cercosporin and an acid-sensitive copolymer multifunctional delivery system with liver tumor cell targeting ability and traceability, and is capable of forming stable nanostructures and triggering explosive release of cercosporin under acidic conditions. Targeted delivery of cercosporin for photodynamic therapy is achieved, which improves the toxicity of cercosporin to hepatoma cells and reduces the toxicity of cercosporin to normal cells. The acid-sensitive copolymer multifunctional delivery system can be a copolymer of poly(N,N-dimethylaminoethyl methacrylate) and poly-3-azido-2-hydroxypropyl methacrylate covalently linked by galactose-modified rhodamine B.
One aspect of the present disclosure relates to an acid-sensitive copolymer multifunctional delivery system with liver tumor cell targeting ability and traceability, which is a compound represented by the following formula 1:
In formula 1,
A is one or more identical or different fluorescent molecules having the fluorescent tracing function selected from rhodamine B, fluorescein isothiocyanate, fluoroboron dipyrrole, etc.;
B is one or more identical or different monosaccharide or oligosaccharide molecules having galactose or galactosamine residues, which are capable of specifically recognizing over-expressed asialoglycoprotein receptors on the surface of hepatoma cells;
formula 1 contains the monomer structure of N,N-dimethylaminoethyl methacrylate (DMAEMA), and m represents the degree of polymerization and is equal to 42;
formula 1 contains the monomer structure of 3-azido-2-hydroxypropyl methacrylate (GMA-N3), and n represents the degree of polymerization and is equal to 62.
In one embodiment of the present disclosure, the acid-sensitive copolymer multifunctional delivery system with liver tumor cell targeting ability and traceability is represented by formula 1, wherein the molar ratio of the fluorescent molecule rhodamine B to DMAEMA to GMA-N3 is 1:42:62, and the molar ratio of the targeting sugar molecule to GMA-N3 is 1:1.
A method for preparing an acid-sensitive copolymer multifunctional delivery system with liver tumor cell targeting ability and traceability, comprising the following steps: modifying a fluorescent molecule with a fluorescent imaging function into a macroinitiator, and triggering free radical polymerization between the monomer 3-azido-2-hydroxypropyl methacrylate (GMA-N3) and N,N-dimethylaminoethyl methacrylate (DMAEMA), thereby forming a polymer covalently bonded with the fluorescent molecule, wherein PGMA-N3 in the polymer has a function of loading a hydrophobic drug through hydrophilic-hydrophobic interaction, and the PDMAEMA moiety can coat a nucleic acid substance due to its large amount of amino groups, and is protonated under acidic conditions, thereby triggering a sponge effect to cause the inclusion bodies to escape; the galactose-terminated position having a liver-targeting function is modified to contain an alkynyl group and can be covalently bonded to the copolymer by a click reaction with an azide group of the PGMA-N3 moiety in the copolymer, thereby providing a stable targeting function for a vector.
The method further comprises:
adding bromo-rhodamine B initiator, monomer DMAEMA and monomer GMA-N3 into a 25 mL round bottom flask according to a molar ratio of 1:25:50, dissolving with 2 mL of tetrahydrofuran, and introducing argon gas for 30 minutes to remove oxygen from the flask, wherein a stabilizer needs to be removed from the monomer DMAEMA in advance, that is, enabling crude DMAEMA to quickly pass through a basic alumina column; under a nitrogen protection condition, successively adding copper bromide and pentamethyldiethylenetriamine, sealing the flask and reacting at room temperature for 8 hours under the nitrogen protection condition; after the reaction is completed, adding tetrahydrofuran (10 mL) into the reaction solution, thoroughly stirring for dissolving the reaction solution in the flask, and passing through a neutral alumina column to remove the copper ligand from the mixed solution; collecting the obtained liquid and removing the solvent by rotary evaporation, slowly dropwise adding the viscous liquid in the flask to petroleum ether (500 mL) to perform precipitating repeatedly for three times, and vacuum drying the obtained precipitate to obtain a rhodamine B-modified copolymer.
Dissolving propargyl modified deacetyl galactose and the rhodamine B modified copolymer in 5 mL of DMF, then dissolving copper sulfate and sodium ascorbate in 5 mL of water and then dropwise adding to the above reaction solution, and stirring the reaction solution at room temperature for 48 hours. Filtering the reaction solution, and dialyzing in an aqueous solution (molecular weight cutoff of a dialysis bag: 8-10 kDa) to obtain a target copolymer Gal-polymer.
A method for preparing a cercosporin-coated multifunctional nanocomposite material, comprising the following steps:
1) respectively dissolving a target copolymer Gal-polymer and cercosporin with DMSO, and mixing and stirring the two solutions for 6 hours;
2) dialyzing the mixed solution in double distilled water for 48 hours, and changing water once every 12 hours to prepare a photosensitizer multifunctional nanocomposite material solution;
3) filtering the photosensitizer multifunctional nanocomposite material solution with a 0.45 μm micromembrane to remove unloaded cercosporin, and performing freeze drying by using a freeze drier to obtain a photosensitizer multifunctional nanocomposite material Cer@Gal-polymer.
A GMA monomer in the acid-sensitive nano-polymer multifunctional delivery system with liver tumor cell targeting ability and traceability according to the present disclosure is used for providing a hydrophobic portion, on the one hand, the GMA monomer interacts with hydrophobic cercosporin to coat the cercosporin in its water delivery core, and on the other hand, the —N3 group of the GMA monomer can chemically react with propargyl-containing galactose to covalently bond and introduce a targeted galactose molecule to the polymer; the DMAEMA monomer is to provide a hydrophilic portion on the one hand, on the other hand, because it contains a large amount of amino groups, it can be protonated under acidic conditions to cause micelle dissociation to release the coated photosensitizer, and it can escape from the endoplasmic reticulum of the cell by triggering a sponge effect, thereby releasing the coated photosensitizer into the cytoplasm or even the nucleus.
The novel photosensitizer multifunctional nanocomposite material according to the present disclosure has the following beneficial effects:
(1) The photosensitizer multifunctional nanocomposite material Cer@Gal-polymer of the present disclosure can stably exist during a transportation process (pH 7.4), photosensitizer leakage can be effectively reduced, and the efficiency of producing singlet oxygen under light irradiation conditions is significantly reduced; while in an acidic pH environment, photosensitizer release is accelerated, the photosensitizer release amount is increased, and a large amount of singlet oxygen is produced so as to produce cytotoxicity.
(2) The photosensitizer multifunctional nanocomposite material Cer@Gal-polymer of the present disclosure can promote real-time imaging in vitro and in vivo because it contains covalently bonded rhodamine B molecules.
(3) The photosensitizer multifunctional nanocomposite material Cer@Gal-polymer of the present disclosure can target over-expressed asialoglycoprotein receptors on the surface of hepatoma cells because it contains covalently linked galactose molecules, thereby realizing targeted delivery.
(4) After being endocytosed into cells via specific recognition of galactose-asialoglycoprotein receptors, the photosensitizer multifunctional nanocomposite material Cer@Gal-polymer of the present disclosure can successfully escape from acidic organelles into cytoplasm or even the nucleus to play the role of the photosensitizer.
Embodiment plan of the present disclosure will be described in detail below with reference to the examples, but those skilled in the art will understand that the following examples are intended to illustrate the present disclosure and are not to be considered as limiting the scope of the present disclosure. If no specific conditions are specified in the examples, operations are carried out according to the general conditions or the conditions recommended by manufacturers. Any reagents or instruments that are not indicated with the manufacturers are commercially available products.
Weighing and putting 15.52 g (25.00 mmol) of ethylene glycol and 1.01 g (10.00 mmol) of triethylamine in a 100 mL erlenmeyer flask and stirring, cooling to 0° C. in an ice water bath, dropwise adding 1.20 mL (10.00 mmol) of 2-bromoisobutyryl bromide under a nitrogen atmosphere, then slowly raising the temperature to room temperature and magnetically stirring for 3 hours. Adding 100 mL of deionized water to the reacted solution for quenching and extracting with dichloromethane (100 mL×3). Extracting the collected organic phase with deionized water (100 mL×3). Adding an appropriate amount of anhydrous magnesium sulfate to the organic phase obtained by extraction, and drying for 12 hours. After filtration, performing rotary evaporation to obtain a crude oily product, and performing distillation under reduced pressure (85° C., 30 mTorr) to obtain a colorless viscous product 2-hydroxyethyl 2-bromoisobutyrate.
Dissolving 4.81 g (10.00 mmol) of rhodamine B, 2.90 g (15.00 mmol) of 1-ethyl-(3-dimethylaminopropyl) carbodiimide hydrochloride and 3.22 g (15.00 mmol) of a compound 2-hydroxyethyl 2-bromoisobutyrate in 40 mL of anhydrous dichloromethane and stirring, cooling to 0° C. in an ice water bath, adding 1.82 g of 4-dimethylaminopyridine (15 μmop, then, slowly raising the temperature to room temperature and reacting for 12 hours. Extracting the reaction solution with 0.1 M of HCl (50 mL×3), then respectively washing with a saturated sodium hydrogen carbonate solution and a saturated saline solution for three times, drying and filtering the organic phase with anhydrous magnesium sulfate, removing the solvent by rotary evaporation, and performing separation with a silica gel column (dichloromethane/methanol=10:1) to obtain the bromo-rhodamine B initiator. Specific methods can be found in the reference (Marcromolecules, 2011, 44, 2050-2057).
Dissolving 3.71 g (57.00 mmol) of sodium azide and 3.81 g (45.20 mmol) of sodium hydrogen carbonate in 60 mL of tetrahydrofuran/water (5:1 v v−1) and stirring, slowly adding 5.42 g (37.80 mmol) of glycidyl methacrylate, and reacting at room temperature for 48 hours. Filtering to remove insoluble salt substances, removing the solvent by rotary evaporation, extracting the obtained concentrate twice with dichloromethane, drying and filtering the obtained organic phase with anhydrous magnesium sulfate, removing the solvent by rotary evaporation, and performing separation with a silica gel column (hexane/ethyl acetate=9:1) to obtain 3-azido-2-hydroxypropyl methacrylate. Specific methods can be found in the references (Polymer Chemistry, 2015, 6, 3875-3884; Soft Matter, 2009, 5, 4788-4796).
Accurately weighing 70.0 mg (0.10 mmol) of bromo-rhodamine B initiator, 484.0 mg (2.75 mmol) of monomer DMAEMA and 1.01 g (5.50 mmol) of compound 3-azido-2-hydroxypropyl methacrylate, adding to a 25 mL round bottom flask, dissolving with 2 mL of tetrahydrofuran, and introducing argon gas for 30 minutes to remove oxygen from the flask, wherein the stabilizer in the monomer DMAEMA needs to be removed in advance, that is, enabling crude DMAEMA to quickly pass through a basic alumina column; under a nitrogen protection condition, successively adding 18.9 mg (0.10 mmol) of CuBr and PMDETA (28 μL, 0.10 mmol), sealing the flask and reacting at room temperature for 8 hours under the nitrogen protection condition. After the reaction is completed, adding tetrahydrofuran (10 mL) to the reaction solution, thoroughly stirring the reaction solution in the flask, and passing through a neutral alumina column to remove the copper ligand from the mixed solution; collecting the obtained liquid and removing the solvent by rotary evaporation, slowly dropwise adding the viscous liquid in the flask to petroleum ether (500 mL) to perform precipitating repeatedly for three times, and vacuum drying the obtained precipitate to obtain the rhodamine B-modified copolymer RhB-PDMAEMA42-c-PGMA62-N3.
Dissolving 6.21 g (15.90 mmol) of peracetyl galactose in 75 mL of anhydrous dichloromethane, adding 1.0 mL (18.00 mmol) of propargyl alcohol, cooling to 0° C. and stirring for 5 minutes, and dropwise adding 3.0 mL (24.30 mmol) of boron trifluoride etherate within 15 minutes. After continuing stirring at 0° C. for 10 minutes, reacting at room temperature for 10 hours. Stopping the reaction with a saturated potassium carbonate solution, extracting the organic phase with dichloromethane, washing the organic phase with a saturated saline solution for three times, drying and filtering the organic phase with anhydrous magnesium sulfate, and removing the solvent by rotary evaporation to obtain the propargyl-modified peracetyl galactose.
Dissolving 2.01 g (5.20 mmol) of propargyl-modified peracetyl galactose in 50 mL of 0.30 mol L−1 sodium methoxide methanol solution and reacting at room temperature. Testing the plate until the disappearance of the starting materials, adjusting the reaction solution to neutral by adding H+ exchange resin, performing filtering, removing the solvent by rotary evaporation, and performing separation with a silica gel column (dichloromethane/methanol=10:1) to obtain the propargyl-modified deacetyl galactose. Specific methods can be found in the reference (Bioconjugate Chemistry, 2012, 23, 1166-1173).
Dissolving 350.0 mg of the propargyl-modified deacetyl galactose of Example 4 and 200.1 mg of the rhodamine B-modified copolymer RhB-PDMAEMA25-c-PGMA50-N3 of Example 3 in 5 mL of DMF, then, dissolving 98.0 mg (0.61 mmol) of copper sulfate and 242.0 mg (1.2 mmol) of sodium ascorbate in 5 mL of water, dropwise adding into the above reaction solution, and stirring the reaction solution at room temperature for 48 hours. Filtering the reaction solution, and dialyzing in an aqueous solution (molecular weight cutoff of a dialysis bag: 8-10 kDa) to obtain a target copolymer Gal-polymer.
Respectively dissolving the copolymer Gal-polymer of Example 5 and cercosporin in DMSO, and mixing and stirring the two solutions for 6 hours. Dialyzing the mixed solution in double distilled water for 48 hours, and changing water once every 12 hours to prepare a cercosporin-loaded photosensitizer multifunctional nanocomposite material solution; then filtering the photosensitizer multifunctional nanocomposite material solution with a 0.45 μm micromembrane to remove unloaded cercosporin, and performing freeze drying by using a freeze drier to obtain a cercosporin-coated photosensitizer multifunctional nanocomposite material Cer@Gal-polymer.
Fully dissolving the prepared photosensitizer multifunctional nanocomposite material in DMSO, and measuring the absorbance of the solution at 463 nm by a microplate reader. The concentration of cercosporin in the composite nanomaterial can be obtained according to the calibration curve prepared by the cercosporin DMSO solution. The loading amount of cercosporin in the obtained photosensitizer multifunctional nanocomposite material=the mass of the cercosporin in the composite material/the mass of the copolymer, which is 9.0%; the encapsulation ratio=the mass of the cercosporin in the composite/the mass of the starting cercosporin, which is 35.6%.
Measuring the particle size distribution of the Cer@Gal-polymer prepared in Example 6 by dynamic light scattering technique, and observing its morphological features by a transmission electron microscope. As shown in
Stability is one of the most important properties of a photosensitizer multifunctional nanocomposite material. Nanoparticles used in biomedical fields must be stably dispersed in a medium. The photosensitizer multifunctional nanocomposite material Cer@Gal-polymer prepared in this experiment is dispersed in a medium containing 10% fetal bovine serum to determine the particle size change. As shown in
Respectively dissolving 12 mg of Cer@Gal-polymer prepared in Example 6 in 1 mL of PBS of pH 5.0 or pH 7.4, filling in dialysis bags (MWCO 2000 Da), and respectively placing the sealed dialysis bags in beakers containing 35 mL of a PBS buffer solution of pH 5.0 or pH 7.4 (each containing 1% Tween 20). Placing the beakers on a constant temperature (37° C.) magnetic stirrer, setting the sampling time, taking 200 μL of the release solutions from the beakers by using a pipette, and replenishing 200 μL of fresh buffer solutions of the corresponding pH values. Measuring the absorption intensity of cercosporin in the release solutions by a microplate reader, and calculating the cumulative release amount.
As shown in the results in
The singlet oxygen production capacity of a photosensitizer is an important indicator for evaluating its application in photodynamic therapy. To evaluate the singlet oxygen production capacity of the photosensitizer cercosporin, the intensity change of the characteristic absorption peak of a singlet oxygen trapping agent 1,3-diphenylisobenzofuran (DPBF) is adopted to characterize the generation of singlet oxygen.
As shown in
9,10-anthryl-bis(methylene)dimalonic acid (ABDA) can be used as an agent for measuring singlet oxygen production in an aqueous solution. When the novel photosensitizer multifunctional nanocomposite material (Cer@Gal-polymer) is under the irradiation of light of a specific wavelength, ABDA can be oxidized by the produced singlet oxygen, thereby enabling its fluorescence intensity to be reduced, and further indirectly characterizing the formation of singlet oxygen of the Cer@Gal-polymer. Respectively adding 150 μL of Cer@Gal-polymer (1 mg mL−1 in PBS of pH 5.0) and 150 μL of Cer@Gal-polymer (1 mg mL−1 in PBS of pH 7.4) to 2 mL of ABDA (13 mM in PBS of pH 5.0 or PBS of pH 7.4), and measuring the fluorescence spectra (400-550 nm) after 10, 20, 30, 40 and 50 seconds of irradiation at 463 nm.
As shown by the results in
In the flow cytometry test, culturing HepG2 and HEK293 cells in DMEM media (containing 100 U/mL penicillin and 100 μg/mL streptomycin) containing 10% newborn bovine serum, and placing in a 37° C. incubator containing 5% CO2 for growth. Taking the cells in the logarithmic growth phase, after digesting with 0.02% EDTA and 0.25% trypsin digestion fluid, inoculating the cells in 6-well plates according to 5×104 cells per well, adding 2 mL of a complete culture solution to each well, placing the culture plate in an incubator and culturing for 24 hours. Adding galactose with a final concentration of 10 mmol L−1 to one group of HepG2 cells, after continuing culturing for 24 hours, when the cell density of each group reaches 70%, continuing culturing for 8 hours by adding Cer@Gal-polymer. Digesting the cells with trypsin, centrifuging at 1000 rpm for 3 minutes, discarding the supernatant, and resuspending and dispersing the cumulative cells in PBS. Repeating the centrifugation process for three times to remove residual media and micelle solutions and reduce interference to fluorescence detection. Finally, dispersing the cells in PBS, placing in a flow tube, and measuring the fluorescence intensity of each group of cells by flow cytometry.
In the experiment, HepG2 cells are cultured by two ways, respectively in a medium containing galactose (the surface receptor is saturated with galactose in advance) and in a medium containing no galactose (the surface asialoglycoprotein receptor is not affected).
As shown in
This experiment demonstrates that Cer@Gal-polymer specifically targets and recognizes receptors on the surface of HepG2 cells and is successfully endocytosed into cells.
Adding the photosensitizer multifunctional nanocomposite material Cer@Gal-polymer obtained in Example 6 to culture solutions to perform cell culture experiments with HepG2 and HEK293 cells, and then staining the nuclei with 4′,6-diamidino-2-phenylindole. It can be seen from the results of laser confocal microscopy experiments in
Inoculating human hepatoma cells HepG2 cells and normal cells HEK293 cells into 96-well plates and culturing in a 37° C. incubator containing 5% CO2 for 24 hours. After the cells are subjected to adherent growth, adding fresh culture solutions containing different concentrations of Cer@Gal-polymer to continue culturing for 3, 6, 12 or 24 hours. Discarding the culture solutions, washing for three times with PBS of pH 7.4, and adding fresh media. Irradiating the culture dishes with light (463 nm, 20 mW/cm2) for 15 minutes and continuing culturing for 12 hours. Removing the culture solutions again, washing twice with a PBS buffer solution, and adding 100 μL of CCK-8 reagent to each well and continuing culturing for 2 hours in an incubator. Measuring the absorbance (OD) of each well at 450 nm with a multi-functional microplate reader to calculate the cell viability. As shown in
The above-mentioned examples are better examples of the present disclosure, but are not restrictions on the examples of the present disclosure. In this field, any other changes, modifications, combinations, substitutions and simplifications that do not depart from the principles and spirit of the present disclosure belong to the equivalent replacement mode and are included in the scope of protection of the claims of the present disclosure.
| Number | Date | Country | Kind |
|---|---|---|---|
| 201810033885.3 | Jan 2018 | CN | national |
| Number | Name | Date | Kind |
|---|---|---|---|
| 20020143066 | Miller | Oct 2002 | A1 |
| 20160331839 | Vanbever | Nov 2016 | A1 |
| Number | Date | Country |
|---|---|---|
| 1531442 | Sep 2004 | CN |
| 103289099 | Sep 2013 | CN |
| 105412924 | Mar 2016 | CN |
| 105646892 | Jun 2016 | CN |
| 105646892 | Jun 2016 | CN |
| 105999282 | Oct 2016 | CN |
| Entry |
|---|
| Sonoke et al, “Galactose-Modified Cationic Liposomes as a Liver-Targeting Delivery System for Small Interfering RNA”, Biol. Pharm. Bull. 34(8) 1338-1342 (2011) (Year: 2011). |
| Number | Date | Country | |
|---|---|---|---|
| 20190224318 A1 | Jul 2019 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | PCT/CN2018/082674 | Apr 2018 | US |
| Child | 16374910 | US |
